商务合作
动脉网APP
可切换为仅中文
MONTRÉAL
蒙特利尔
,
,
April 2, 2025
2025年4月2日
/PRNewswire/ - vopemed (Vope Medical), a pioneering MedTech startup enhancing surgical vision with AI-powered image clarification, has secured an oversubscribed
/PRNewswire/ - vopemed(Vope Medical)是一家先锋医疗科技初创公司,通过人工智能驱动的图像澄清技术提升手术视野,已成功获得超额认购。
$2.29 million
229万美元
pre-seed funding round to accelerate the development and clinical validation of its technology. This funding marks a significant milestone in vopemed's vision of empowering surgical teams with next-generation tools for safer, more efficient surgeries.
预先种子轮融资,以加速其技术的开发和临床验证。这笔资金标志着沃普梅德愿景中的一个重要里程碑,即为手术团队提供更安全、更高效的下一代工具。
vopemed is developing Claris, an AI-driven image enhancement software designed to improve the clarity of laparoscopic and robotic-assisted procedure video feeds in real-time, leading to safer surgeries.
vopemed 正在开发Claris,这是一款由人工智能驱动的图像增强软件,旨在实时提高腹腔镜和机器人辅助手术视频的清晰度,从而实现更安全的手术操作。
'This funding validates the need for enhanced surgical visualization and reinforces our mission to bring AI-powered image enhancement into every operating room,' said
“这笔资金验证了增强手术可视化的需求,并进一步巩固了我们将人工智能驱动的图像增强技术带入每个手术室的使命,”
Amy Lorincz
艾米·洛林茨
, CEO and co-founder of vopemed. 'Current solutions fail to address persistent visibility challenges in minimally invasive surgery, and Claris is designed to solve this unmet need.'
Vopemed的首席执行官兼联合创始人表示:“当前的解决方案未能解决微创手术中持续存在的可见性挑战,而Claris旨在满足这一未被满足的需求。”
'We are excited to support vopemed as they bring AI-driven image enhancement to surgery,' said
“我们很高兴支持vopemed,因为他们将人工智能驱动的图像增强技术带入手术领域,”
Jacques Courtois
雅克·库尔图瓦
of Genson Capital Inc. 'Their technology has the potential to significantly improve surgical precision and efficiency, and we believe they are well-positioned to make a lasting impact in MedTech.'
Genson Capital Inc. 的评价是:“他们的技术有潜力显著提高手术的精确性和效率,我们相信他们在医疗技术领域将能够产生持久的影响。”
'Clear visualization is critical for precise surgical decisions, especially in minimally invasive procedures. AI-driven image enhancement like Claris could be a game-changer in improving efficiency and patient outcomes,' said Dr.
“清晰的可视化对于精确的手术决策至关重要,尤其是在微创手术中。像Claris这样由人工智能驱动的图像增强技术可能会彻底改变提高效率和患者预后的局面,”博士说道。
Dicken Ko
迪肯·科
, Urologic Surgeon, Professor of Surgery at The Warren Alpert Medical School of
泌尿外科医生,沃伦·阿尔珀特医学院外科教授
Brown University
布朗大学
.
。
The pre-seed round was led by Genson Capital Inc., which invested
种子前轮融资由 Genson Capital Inc. 领投,其投资了
$1.5 million
150万美元
CAD, and Investissement Québec, as a mandated agent of the gouvernement du Québec, which contributed
CAD,以及作为魁北克政府授权代理的Investissement Québec,作出了贡献
$750,000
75万美元
CAD. These investors bring valuable support to life science and medical device companies, enabling them to advance innovation and scale in a regulated industry.
计算机辅助设计。这些投资者为生命科学和医疗设备公司提供了宝贵的支持,使他们能够在受监管的行业中推进创新并扩大规模。
With the funds secured, vopemed will expand R&D, refine its software for broader clinical applications, and strengthen partnerships with hospitals and surgical teams. The company is also preparing for clinical validation studies to further demonstrate Claris' impact in real-world settings.
随着资金到位,Vopemed将扩大研发规模,完善其软件以适用于更广泛的临床应用,并加强与医院和外科团队的合作。该公司还正在准备进行临床验证研究,以进一步证明Claris在真实环境中的影响。
About vopemed
关于vopemed
vopemed is a MedTech startup dedicated to enhancing surgical vision with AI-powered image clarification technology. Its flagship product, Claris, integrates seamlessly with existing surgical systems to provide real-time, high-clarity imaging, reducing visual obstructions and improving visualization in minimally invasive surgery.
vopemed 是一家致力于通过人工智能图像增强技术提升手术视野的医疗科技初创公司。其旗舰产品 Claris 能够与现有手术系统无缝集成,提供实时的高清晰度成像,减少视觉障碍,改善微创手术中的可视化效果。
The company is committed to redefining surgery by equipping surgical teams with cutting-edge tools for safer, more efficient procedures..
公司致力于通过为手术团队配备尖端工具以重新定义手术,实现更安全、更高效的手术过程。
SOURCE vopemed
来源 vopemed
WANT YOUR COMPANY'S NEWS
想要贵公司的新闻
FEATURED ON PRNEWSWIRE.COM?
刊登在PRNEWSWIRE.COM上?
440k+
44万+
Newsrooms &
新闻编辑室 &
Influencers
影响者
9k+
9k+
Digital Media
数字媒体
Outlets
插座
270k+
27万+
Journalists
记者
Opted In
已选择加入
GET STARTED
开始使用